Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-14

FDA Approved: INFED — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for INFED (iron dextran) from Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFED (iron dextran)

Snippet

SUPPL AP for INFED (IRON DEXTRAN)